FOXO TECHNOLOGIES INC. Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares
FOXO TECHNOLOGIES INC. (FOXO) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 168 shares for the 3-month period ending 2025-03-31, per its 10-Q/A filed 2025-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2025-08-19
- FOXO TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2025-03-31 was 168.00 shares, a 77.72% decline year-over-year.
- FOXO TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2024-03-31 was 754.00 shares, a 99.82% decline year-over-year.
- FOXO TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2023-03-31 was 423.70K shares.
- FOXO TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2024 was 3.33K shares, a 78.72% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2023 was 15.67K shares, a 96.40% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2022 was 434.80K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 9 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 12 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | 168.00 shares 10-Q/A · filed 2025-08-19 | 333.00 shares 10-Q · filed 2025-05-20 | |||||
| 2024-12-31 | 3.33K shares 10-K · filed 2025-04-15 | ||||||
| 2024-09-30 | 3.33K shares 10-Q · filed 2024-11-19 | ||||||
| 2024-06-30 | 13.33K shares 10-Q · filed 2024-08-19 | ||||||
| 2024-03-31 | 754.00 shares 10-Q/A · filed 2025-08-19 | 15.00K shares 10-Q · filed 2024-06-28 | |||||
| 2023-12-31 | 15.67K shares 10-K · filed 2025-04-15 | ||||||
| 2023-09-30 | 69.67K shares 10-Q · filed 2024-11-19 | ||||||
| 2023-06-30 | 398.70K shares 10-Q · filed 2024-08-19 | 3.99M shares 10-Q · filed 2023-08-10 | |||||
| 2023-03-31 | 423.70K shares 10-Q · filed 2024-06-28 | 4.24M shares 10-Q · filed 2023-05-11 | |||||
| 2022-12-31 | 434.80K shares 10-K · filed 2024-06-06 | 4.35M shares 10-K · filed 2023-03-31 | |||||
| 2022-09-30 | 9.18M shares 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |